Press release
Global Diverticular Disease Therapeutics Market Expected to Secure Notable Revenue Share during 2018-2028 || Key players- Shire Plc., Cook Group Incorporated, Allergen Plc., SCLNOW BIOTECHNOLOGY CO., Sandoz (Novartis AG), Glaxosmithkline Inc., Pfizer Inc.
The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the diverticular disease therapeutics market over the forecast period. According to the World Journal of Gastrointestinal Pharmacology and Therapeutics, the prevalence of diverticular disease has increased from 35% to 50% in the last three decades. Changes is lifestyle and eating habits are attributed to growing prevalence of diverticular disease. Launch and addition of new therapies is the other factor contributing to the growth of the global Diverticular Disease Therapeutics Market. For instance, Cook Group Incorporated is evaluating Hemospray device in phase 2 clinical trial to control colonic bleeding in severe diverticular disease. Shire Plc. is evaluating SPD476 and SPD476 MMX in phase 3 clinical trial to reduce recurrence of diverticulitis.Request a brochure of the report: https://www.factmr.com/connectus/sample?flag=B&rep_id=930
Diverticular disease commonly occurs in people age above 40 years and the prevalence is increasing over the time. Approximately 10% of people over age 40 and 50% of people over age 60 encounter diverticular disease at some point in time. The disease was first identified in the 1930s, to share many of the hallmarks of inflammatory bowel disease. Diverticular disease is characterized by formation of small bulge or sacks called diverticula in the wall of colon. The sigmoid colon is more prone to formation of diverticula. These sacks may range from pea-size to much larger. The disease is associated with symptoms such as pain, bloating, nausea, diarrhea or constipation. Many of these symptoms are similar to inflammatory bowel disease. 20% of the patients may develop severe complications of diverticular disease such as abdominal or rectal bleeding. Diverticular disease are of three types viz. symptomatic uncomplicated diverticular disease, recurrent symptomatic diverticular disease and complicated diverticular disease. Standard treatment recommended for diverticular disease includes antibiotic therapies. Mesalazine (Asacol) and rifaximin (Xifaxan) are commonly recommended antibiotics for diverticular disease. Alternative therapies such as probiotics and diet modification may provide symptomatic relief and prevent recurrence, but are recommended along with standard antibiotics. There are two stages of diverticular disease viz. diverticulosis (presence of diverticula without complications) and diverticulitisan (inflammatory condition caused by perforation of the diverticula). Surgical treatment may be required in case of acute and recurrent diverticulitis.
Diverticular Disease Therapeutics Market: Segmentation
Tentatively, the global diverticular disease therapeutics market can be segmented on the basis of treatment, indication, distribution channel, and geography.
Based on treatment, the global diverticular disease therapeutics market is segmented as:
Antibiotics Treatment
Symptomatic Treatment
Based on indications, the global diverticular disease therapeutics market is segmented as:
Symptomatic Uncomplicated Diverticular Disease
Recurrent Symptomatic Diverticular Disease
Complicated Diverticular Disease.
Based on distribution channel, the global diverticular disease therapeutics market is segmented as:
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
Diverticular Disease Therapeutics Market: Overview
The global market for diverticular disease therapeutics is expected to witness moderate growth over the forecast period. Majority of the antibiotics are introduced in the generic market and thus there exists a high competition among local and regional players. Among the two treatment types, the antibiotic treatment segment is expected to lead in the global diverticular disease therapeutics market over the forecast period. Retail pharmacy distribution channel is expected to contribute high share in the global diverticular disease therapeutics market as it is the most accessible channel and majority of patients are recommended for outpatient treatment.
To get complete report about Diverticular Disease Therapeutics Market, Visit: https://www.factmr.com/report/930/diverticular-disease-therapeutics-market
Diverticular Disease Therapeutics Market: Regional Outlook
Geographically, the global diverticular disease therapeutics market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant market in the global diverticular disease therapeutics market owing to high prevalence of the disease. The diverticular disease therapeutics market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of product offerings by the key players. Europe is expected to have second large share in the global diverticular disease therapeutics market throughout the forecast period.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes
North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
For Further Insights and Segment-Specific Information, Contact a Market Analyst at: https://www.factmr.com/connectus/sample?flag=AE&rep_id=930
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Diverticular Disease Therapeutics Market Expected to Secure Notable Revenue Share during 2018-2028 || Key players- Shire Plc., Cook Group Incorporated, Allergen Plc., SCLNOW BIOTECHNOLOGY CO., Sandoz (Novartis AG), Glaxosmithkline Inc., Pfizer Inc. here
News-ID: 1293854 • Views: …
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Diverticular
Global Diverticular Treatment Market Set for Significant Growth as Awareness and …
The global diverticular treatment market is poised for steady expansion over the next decade, fueled by rising incidences of diverticular disease, increasing elderly population, technological advancements in diagnostics, and a growing preference for non-invasive treatments. Industry stakeholders are witnessing a shift in treatment protocols, innovation in pharmaceutical formulations, and expanding healthcare access in emerging economies.
Get a free sample report: https://datahorizzonresearch.com/request-sample-pdf/diverticular-treatment-market-4125
Understanding Diverticular Disease and the Market Landscape
Diverticular disease, encompassing diverticulosis and…
North America Diverticular Treatment Market to Surpass US$ 1.9 Bn by 2031 Amid R …
The North America Diverticular Treatment Market was valued at US$ 986.6 Mn in 2022 and is projected to expand at a CAGR of 7.6% from 2023 to 2031, surpassing US$ 1.9 Bn by the end of 2031. Increasing healthcare awareness, advancements in drug formulations, and improvements in diagnostic technologies are fueling market growth.
Diverticular disease, a condition characterized by the formation of small pouches (diverticula) in the walls of the colon,…
North America Diverticular Treatment Market Size is Anticipated to Grow at a CAG …
Diverticular disease encompasses a spectrum of conditions ranging from asymptomatic diverticulosis to symptomatic diverticulitis, characterized by inflammation and infection of the diverticula, leading to abdominal pain, bloating, changes in bowel habits, and complications such as abscess formation, perforation, and fistula formation. The prevalence of diverticular disease is increasing, particularly in Western countries such as the United States and Canada, attributed to aging populations, dietary factors, and lifestyle habits.
North America Diverticular…
Diverticular Treatment Market Size 2021 with Key Players Growth Opportunities an …
Latest released, the research study on Global Diverticular Treatment Market Research Report 2021, report comprises growth rate, size, analysis by type, market segment by Application, market competition by manufacturers, share by region, manufacturing cost analysis, Also, the Diverticular Treatment Market offers market breakdown, competitive situation and trends, key raw materials analysis, dynamics, forecast by type, by application and revenue estimates with covid-19 impact till 2027.
Get Free sample copy of the…
Diverticular Disease Market Expected to Grow 7.5% CAGR with Sucampo Pharmaceutic …
Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period.
Market Scenario:
Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber…
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.
Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period.
Market Scenario:
Diverticular disease is a digestive condition…